These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Rodríguez-Fernández K; Reynaldo-Fernández G; Reyes-González S; de Las Barreras C; Rodríguez-Vera L; Vlaar C; Monbaliu JM; Stelzer T; Duconge J; Mangas-Sanjuan V Biomed Pharmacother; 2024 Jan; 170():115977. PubMed ID: 38056237 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans. Hernandez W; Gamazon ER; Aquino-Michaels K; Smithberger E; O'Brien TJ; Harralson AF; Tuck M; Barbour A; Cavallari LH; Perera MA J Thromb Haemost; 2017 Apr; 15(4):735-743. PubMed ID: 28135054 [TBL] [Abstract][Full Text] [Related]
12. Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study. M Hidjo MM; Chikwambi Z; Ngwende G; Matenga JA; Masimirembwa C Pharmacogenomics; 2023 Jul; 24(10):529-538. PubMed ID: 37435666 [No Abstract] [Full Text] [Related]
13. Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing. Crawford DC; Ritchie MD; Rieder MJ Pharmacogenomics; 2007 May; 8(5):487-96. PubMed ID: 17465713 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulation. Salinger DH; Shen DD; Thummel K; Wittkowsky AK; Vicini P; Veenstra DL Pharmacogenet Genomics; 2009 Dec; 19(12):965-71. PubMed ID: 19881396 [TBL] [Abstract][Full Text] [Related]
16. VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study. González Della Valle A; Khakharia S; Glueck CJ; Taveras N; Wang P; Fontaine RN; Salvati EA Clin Orthop Relat Res; 2009 Jul; 467(7):1773-80. PubMed ID: 19034590 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of warfarin dosing in patients of African and European ancestry. Shendre A; Dillon C; Limdi NA Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882 [TBL] [Abstract][Full Text] [Related]
18. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Cavallari LH; Perera M; Wadelius M; Deloukas P; Taube G; Patel SR; Aquino-Michaels K; Viana MA; Shapiro NL; Nutescu EA Pharmacogenet Genomics; 2012 Feb; 22(2):152-8. PubMed ID: 22158446 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of warfarin in populations of African descent. Suarez-Kurtz G; Botton MR Br J Clin Pharmacol; 2013 Feb; 75(2):334-46. PubMed ID: 22676711 [TBL] [Abstract][Full Text] [Related]
20. Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study. Claudio-Campos K; Labastida A; Ramos A; Gaedigk A; Renta-Torres J; Padilla D; Rivera-Miranda G; Scott SA; Ruaño G; Cadilla CL; Duconge-Soler J Front Pharmacol; 2017; 8():347. PubMed ID: 28638342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]